You are here: Industry Insights > study

News List

Type 2 Diabetes More Common in Patients With Psoriasis drugs
December 12, 2019
Rates of type 2 diabetes may be higher among patients with psoriasis, according to a study published online in the Journal of the European Academy of Dermatology and Venereology.
Bryostatin-1 Study Does Not Meet Primary Endpoint americanpharmaceuticalreview
September 10, 2019
Neurotrope announced its confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD did not achieve statistical significance on the primary endpoint...
CTI BioPharma to Move to Phase 3 Study of Pacritinib for Myelofibrosis americanpharmaceuticalreview
July 19, 2019
CTI BioPharma announced the outcome of a Type B, End-of-Phase-2a meeting with the U.S. Food and Drug Administration (FDA) for the continued development of its investigational myelofibrosis treatment candidate, pacritinib. Following this meeting ...
Why Older Women Have Less Sex: It's Not as Simple as You Think drugs
July 11, 2019
More than biology is at play when it comes to why older women have less sex as they age.
NeuroRx Initiates NRX-101 Study for Suicidal Bipolar Depression americanpharmaceuticalreview
July 11, 2019
NeuroRx has initiated a pivotal Phase 2b/3 study for NRX-101 for the treatment of patients with Severe Bipolar Depression and Acute Suicidal Ideation and Behavior (ASIB).
EIP Pharma Initiates Neflamapimod Study americanpharmaceuticalreview
July 10, 2019
EIP Pharma announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with Huntington's disease, a rare, genetically inherited disease that causes the nerve cells of ...
4D pharma Commences Phase I/II Asthma Trial americanpharmaceuticalreview
July 09, 2019
4D pharma has announced an update on its lead Live Biotherapeutic candidate for asthma, MRx-4DP0004.
Study finds common cold virus could help kill bladder cancer tumours pharmaceutical-technology
July 08, 2019
A study by the University of Surrey and Royal Surrey County Hospital in the UK has demonstrated that a strain of the common cold virus could help the immune system to kill non-muscle invasive bladder cancer (NMIBC).
Precigen Announces First Patient Dosed in PRGN-3006 UltraCAR-T™ Study americanpharmaceuticalreview
June 28, 2019
Precigen announced that the first patient has been dosed with PRGN-3006, a first-in-class investigational therapy using Precigen's non-viral UltraCAR-T™ therapeutic platform.
Study reveals impressive success of widespread HPV vaccination pharmaceutical-technology
June 28, 2019
Researchers from Laval University, Canada, have found that five to eight years after vaccination there was a significant reduction in the prevalence of multiple types of human papillomavirus (HPV) and related conditions across the developed world.

Previous page 1 2 3 4 5 Next page